Northwire Canada EditionWednesday, July 15, 2026
Sign inSubscribe
Northwire
⌕
EFF 0.030 +20.0% W 0.500 +1.0% RDG 0.160 +0.0% ARIC 0.780 +4.0% VROY 3.44 +5.2% ROCK 3.81 +3.0% APMI 0.120 +0.0% EM 3.58 −4.8% ALS 66.04 +6.8% MEK 0.065 +44.4% TLO 6.00 +13.0% ADE 0.045 −66.7% FAIR 0.060 +33.3% SVRS 0.420 −2.3% RES 0.050 +42.9% CYG 0.120 +0.0% EFF 0.030 +20.0% W 0.500 +1.0% RDG 0.160 +0.0% ARIC 0.780 +4.0% VROY 3.44 +5.2% ROCK 3.81 +3.0% APMI 0.120 +0.0% EM 3.58 −4.8% ALS 66.04 +6.8% MEK 0.065 +44.4% TLO 6.00 +13.0% ADE 0.045 −66.7% FAIR 0.060 +33.3% SVRS 0.420 −2.3% RES 0.050 +42.9% CYG 0.120 +0.0%

Healthcare

Page 62
  1. Feb 12, 2026 · 09:00 · GSD

    Devonian reports additional molecular data from MASH liver study

    Devonian reports additional molecular data from MASH liver study

    01
  2. Feb 12, 2026 · 09:00 · ONCO

    Onco-Innovations Announces Amendment to Private Placement Pricing

    Onco-Innovations Announces Amendment to Private Placement Pricing

    02
  3. Feb 12, 2026 · 07:25 · KNE

    Kane Biotech Restarts Commercial Activities and Strengthens North American Management

    Kane Biotech Restarts Commercial Activities and Strengthens North American Management

    03
  4. Feb 12, 2026 · 07:20 · MBX

    Microbix Reports Results for Q1 2026

    Microbix Reports Results for Q1 2026

    04
  5. Feb 12, 2026 · 07:00 · MSCL

    Satellos Announces First Participant Dosed in Phase 2 Pediatric Study of SAT-3247 for Duchenne Muscular Dystrophy

    Satellos Announces First Participant Dosed in Phase 2 Pediatric Study of SAT-3247 for Duchenne Muscular Dystrophy

    05
  6. Feb 12, 2026 · 06:31 · CHS

    Comprehensive Healthcare Systems Announces Closing of First Tranche of Private Placement

    Comprehensive Healthcare Systems Announces Closing of First Tranche of Private Placement

    06
  7. Feb 12, 2026 · 03:45 · 4565

    Nxera Pharma to Receive $1.8 Million Milestone Payment from Centessa Pharmaceuticals

    Nxera Pharma to Receive $1.8 Million Milestone Payment from Centessa Pharmaceuticals

    07
  8. Feb 12, 2026 · 03:37 · 4565

    Nxera Pharma Licenses GPCR-targeted Program to Newly Founded Spin-out Company

    Nxera Pharma Licenses GPCR-targeted Program to Newly Founded Spin-out Company

    08
  9. Feb 12, 2026 · 02:15 · VPT

    Ventripoint to issue 291,344 shares for interest

    Ventripoint to issue 291,344 shares for interest

    09
  10. Feb 11, 2026 · 17:31 · MDP

    Medexus Announces Fiscal Q3 2026 Results, Driven by Continued Strong Year-To-Date Product-Level Performance of GRAFAPEX (treosulfan) for Injection

    Medexus Announces Fiscal Q3 2026 Results, Driven by Continued Strong Year-To-Date Product-Level Performance of GRAFAPEX (treosulfan) for Injection

    10
  11. Feb 11, 2026 · 04:27 · OTC

    Ocumetics enters forbearance deal with debentureholders

    Ocumetics enters forbearance deal with debentureholders

    11
  12. Feb 10, 2026 · 17:48 · HELP

    Cybin appoints Cola CEO

    Cybin appoints Cola CEO

    12
  13. Feb 10, 2026 · 17:15 · CRDL

    Cardiol sees phase 2 Archer study results published

    Cardiol sees phase 2 Archer study results published

    13
  14. Feb 10, 2026 · 17:09 · THRM

    Therma portfolio co. completes FIH stroke cohort

    Therma portfolio co. completes FIH stroke cohort

    14
← Newer Older →